Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|July 1, 1982
Human, bovine, and equine growth hormone antibodies in patients treated with human growth hormoneE Poskus, C Peña, A R Pérez, et al.
Surgical Endoscopy|December 5, 2018
Propensity score-matched comparison of short-term and long-term outcomes between endoscopic submucosal dissection and surgery for treatment of early gastric cancer in a Western settingR Bausys, A Bausys, J Stanaitis, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 9, 2012
Common variants in SOCS7 gene predict obesity, disturbances in lipid metabolism and insulin resistanceM L Tellechea, A Penas Steinhardt, G Rodriguez, et al.
Techniques in Coloproctology|July 30, 2025
Quality of life following ileostomy takedown: single-centre, retrospective clinical trial-does closure time matter?G Didrikaite, M Klimovskij, I Civilka, et al.
Clinical Immunology and Immunopathology|February 1, 1993
Detection of autoantibodies against hGH in sera of idiopathic hypopituitary childrenA S Llera, A I Cardoso, R R Stumpo, et al.
Techniques in Coloproctology|November 30, 2016
Transversus abdominis plane block for postoperative pain relief after hand-assisted laparoscopic colon surgery: a randomized, placebo-controlled clinical trialR Tikuisis, P Miliauskas, V Lukoseviciene, et al.
Acta Endocrinologica|September 1, 1985
Antibodies against animal growth hormones appearing in patients treated with human growth hormone: their specificities and influence on growth velocityA R Pérez, C Peña, E Poskus, et al.
Techniques in Coloproctology|March 19, 2022
Robotic colorectal surgery using the Senhance® robotic system: a single center experienceN E Samalavicius, A Dulskas, V Janusonis, et al.
Acta Endocrinologica|July 1, 1993
Heterologous humoral immune response in patients treated with human growth hormone from different sourcesA I Cardoso, A S Llera, R F Iacono, et al.
Diabetologia|December 1, 1992
Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failureA V Zavala, L E Fabiano de Bruno, A I Cardoso, et al.
Pageof 4